Abstract
The purpose of this study is to demonstrate the feasibility of anaerobic treatment of pharmaceutical and baker's yeast industry effluents in a joint treatment system. Anaerobic treatability studies have been performed in a lab-scale upflow anaerobic sludge blanket reactor (UASBR). The experimental study has been carried out for 333 days. The influent COD's during the experimental study were about 10,000 mg/l. Pharmaceutical wastewater has a 5% of inhibition on the COD removals at the dilution rate of 1/100 or more in the joint anaerobic treatment with baker's yeast industry effluents. Maximum inhibition of 10% on the average was observed when the system was characterized with acclimation periods. The study has shown that, following the solvent extraction with pre-aeration process, a common anaerobic treatment can be applied to baker's yeast industry wastewater and to pharmaceutical industry effluents.
| Original language | English |
|---|---|
| Pages (from-to) | 37-44 |
| Number of pages | 8 |
| Journal | Water Science and Technology |
| Volume | 38 |
| Issue number | 4-5 -5 pt 4 |
| DOIs | |
| Publication status | Published - 1998 |
| Event | Proceedings of the 1998 19th Biennial Conference of the International Association on Water Quality. Part 1 (of 9) - Vancouver, Can Duration: 21 Jun 1998 → 26 Jun 1998 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 6 Clean Water and Sanitation -
SDG 9 Industry, Innovation, and Infrastructure
Keywords
- Acclimation
- Anaerobic treatment
- Baker's yeast
- Industry effluents
- Inhibition
- Pharmaceutical industry effluents
Fingerprint
Dive into the research topics of 'Common anaerobic treatability of pharmaceutical and yeast industry wastewater'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver